Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis

BACKGROUND: PYRAMID was an international post‐marketing registry that aimed to collect data on the long‐term safety and effectiveness of adalimumab treatment per local standard of care in patients with moderately to severely active Crohn's disease (CD). Here, we present post hoc analyses of obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, Ailsa, D’Haens, Geert, Bereswill, Mareike, Finney‐Hayward, Tricia, Kalabic, Jasmina, Levy, Gweneth, Liang, Huifang, Seow, Cynthia H., Loftus, Edward V., Panaccione, Remo, Reinisch, Walter, Satsangi, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189454/
https://www.ncbi.nlm.nih.gov/pubmed/35560533
http://dx.doi.org/10.1002/ueg2.12236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189454/
https://www.ncbi.nlm.nih.gov/pubmed/35560533
http://dx.doi.org/10.1002/ueg2.12236

Ejemplares similares